References
1. Engin A. The defi nition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017; 960: 1-17. doi: 10.1007/978-3-319-48382-5_1
2. Ng M., Fleming T., Robinson M., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384: 766-81. doi: 10.1016/S0140-6736(14)60460-8
3. Zeng X., Xie Y.J., Liu Y.T., et al. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2019; 13: 7-18. doi: 10.1016/j.cca.2019.11.003
4. Yuyan Pan, Jiaqi Liu, Fazhi Qi. Identification of key candidate genes and molecular pathways in white fat browning: an anti-obesity drug discovery based on computational biology. Hum Genomics. 2019; 13: 55. doi: 10.1186/s40246-019-0239-x
5. Lapik I.A., Gapparova K.M., Chekhonina Yu.G., et al. Current trends in nutrigenomics of obesity. Voprosy pitaniia [Problems of Nutrition]. 2016; 85 (6): 6-11. (in Russian)
6. Kopp W. How western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes. 2019; 12: 2221-36. doi: 10.2147/DMSO.S216791
7. Niswender K. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. Diabetes Obes Metab. 2010; 12: 267-87. doi: 10.1111/j.1463-1326.2009.01175.x
8. Arutyunov G.P., Babak S.L., Vasyuk Yu.A., et al. Diagnosis, treatment, prevention of obesity and associated diseases: National clinical guidelines. Saint Petersburg, 2017: 57-70. (in Russian)
9. Tamba S., Nishizawa H., Funahashi T. et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Int Med 2008; 47: 1175-80. doi: 10.2169/internal medicine.47.0603
10. Ichikawa N., Taniguchi A., Urano W., et al. Comorbidities in patients with gout. Nucleosides Nucleotides Nucleic Acids. 2011; 30: 1045-50. doi: 10.1080/15257770.2011.596499
11. Inokuchi T., Tsutsumi Z., Takahashi S., et al. Increased frequency of metabolic syndrome and its individual metabolic abnormalities in Japanese patients with primary gout. J Clin Rheumatol. 2010; 16: 109-12. doi: 10.1097/RHU.0b013e3181c6802e
12. Orlova EV. Hyperuricemia in therapeutic practice: to treat or to observe. Trudniy patsient [Difficult Patient]. 2018; (10): 16-23. doi: 10.24411/2074-1995-2018-10015 (in Russian)
13. Choi H.K., Ford E.S., Li C., et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007; 57: 109-15.
14. Novak S., Melkonian A.K., Patel P.A., et al. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use. Curr Med Res Opin. 2007; 23: 623-30. doi: 10.1185/030079906X167651
15. Pogozheva A.V. Standards of medical nutrition of patients with obesity. Prakticheskaya dietologiya [Practical Dietology]. 2012; (4): 54. (in Russian)
16. Gonzalez-Campoy J., St Jeor S.T., Castorino K., et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists. Endocr Pract. 2013; 19 (3): 1-82. doi: 10.4158/EP13155.GL.
17. Lapik I.A., Sharafetdinov Kh.Kh., Plotnikova O.A., et al. Influence of dietotherapy on body composition in patients with obesity and diabetes mellitus type 2. Voprosy pitaniia [Problems of Nutrition]. 2013; 82 (1): 53-8. (in Russian)
18. Tutelyan V.A. On norms of physiological needs in energy and food substances for different groups of the population of the Russian Federation. Voprosy pitaniia [Problems of Nutrition]. 2009; 78 (1): 4-15. (in Russian)
19. Sharafetdinov Kh.Kh., Plotnikova O.A., Lapik I.A. The effect of a specialized food product for body weight control on appetite in obese patients. Voprosy dietologii [Problems of Dietology]. 2014; 4 (1): 47-52. (in Russian)
20. Zychowicz M.E. Gout: No longer the disease of kings. Orthop Nurs. 2011; 30: 322-30. doi: 10.1097/NOR.0b013e31822c5aa7.
21. Dzhanashiya P.Kh., Didenko V.A. Hyperuricemia, arterial hypertension and chronic kidney disease: interconnection and management strategy. Klinicheskaya nefrologiya [Clinical Nephrology]. 2010; 4 (4): 3-11. (in Russian)
22. Soltani Z., Rasheed K., Kapusta D.R., Reisin E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hyper-tens. 2013; 15: 175-81. doi: 10.1007/s11906-013-0344-5
23. Braga F., Pasqualetti S., Ferraro S., Panteghini M. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med. 2016; 54: 7-15. doi: 10.1515/cclm-2015-0523
24. Muiesan M.L., Agabiti-Rosei C., Paini A., Salvetti M. Cardiolvascular risk factors uric acid and cardiovascular disease: an update. Eur Cardiol. 2016; 11: 54-9. doi: 10.15420/ecr.2016
25. Major T.J., Topless R.K., Dalbeth N., Merriman T.R. Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. BMJ. 2018; 363: k3951. doi: 10.1136/ bmj.k3951
26. Zykova S.N., Storhaug H.M., Toft I., Chadban S.J., Jenssen T.G., White S.L. Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromso study. Nutr J. 2015; 14 (1): 49. doi: 10.1186/s12937-015-0032-1
27. Jakse B, Pajek M., Pajek J. Uric acid and plant-based nutrition. Nutr J. 2019; 11: 17-38. doi: 10.3390/nu11081736